Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Lunit
AI-driven cancer diagnostics and oncology solutions utilizing medical imaging data.
What they do
The company develops advanced software that analyzes mammograms, chest X-rays, and pathology slides to detect cancer markers early. They sell their diagnostic solutions to medical systems, hospitals, and pharmaceutical developers looking to optimize cancer therapy selection.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Clinical AI triage
- Product type
- Software as a medical device
- Stage
- Public
- Headquarters
- Seoul, South Korea
- Region
- Asia-Pacific
- Founded
- 2013
- Total funding
- $130M raised
Notable investors: SoftBank Ventures Asia, Legend Capital, Shinhan Card.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
De Novo AI in the Acute Care Pathway: How Queen of Hearts Redefines Emergency Triage Economics and Cath Lab Utilization
Dr. Dereck Mush, MD, MBA
Decentralizing the Neuro-ICU: The Clinical Economics of Quantitative Bedside Brain Monitoring
Dr. Dereck Mush, MD, MBA
The MCED Inflection Point: What Galleri's FDA Panel Backing Means for Cancer Screening
Dr. Dereck Mush, MD, MBA